Grant
New research in Esbjerg: Can weight loss ease atrial fibrillation?
A donation of DKK 17.8 million from the Novo Nordisk Foundation is enabling Clinical Professor Axel Brandes and his research team in Esbjerg to launch a major national study on atrial fibrillation.
The researchers will follow nearly 500 participants to investigate whether weight loss can reduce atrial fibrillation – also known as AF – in people who are overweight. Participants will receive support from dietitians and be closely monitored through regular heart rhythm measurements.
If the study confirms a link, it could eventually lead to fewer symptoms, better quality of life and fewer hospital visits for people living with AF.
The project involves several hospitals across Denmark and is expected to provide new insights that could play a key role in shaping future treatment for atrial fibrillation.
Meet the researcher
Axel Brandes is a clinical professor in cardiology at Department of Regional Health Research and Esbjerg & Grindsted Hospital.
What is atrial fibrillation?
Atrial fibrillation is a type of heart rhythm disorder where the heart beats rapidly and irregularly. It can cause symptoms such as palpitations, fatigue and shortness of breath – although some people experience no symptoms at all.
AF is the most common type of heart rhythm disorder and increases the risk of stroke. Treatment may include medication, lifestyle changes such as weight loss and exercise, or, in some cases, a minor procedure.